Akeso Says FDA Letter May Explain Unusual Share Price Moves
Akeso said Nov. 16 that an FDA complete response letter may explain unusual moves in its share price.
Akeso said Nov. 16 that an FDA complete response letter may explain unusual moves in its share price.